Jump to content

Allergan, Inc.

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Whisoseryus (talk | contribs) at 07:43, 10 February 2014 (Added "Corporate Affairs"). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Allergan, Inc.
Company typePublic
IndustryPharmaceuticals
Founded1948
HeadquartersIrvine, California
Key people
ProductsBotox, Acular, Acuvail, Alocril, Prevage, Avage, Tazorac, Juvederm, Lap-band, Restasis, Alphagan, Ganfort, Hydrafill, Optive
RevenueIncrease US$5.8 Billion (2012)[1]: F-5 
Increase US$1.6 Billion (2012)[1]: F-5 
Increase US$1.1 Billion (2012)[1]: F-6 
Total assetsIncrease US$9.2 Billion (2012)[1]: F-4 
Total equityIncrease US$5.9 Billion (2012)[1]: F-4 
Number of employees
10,800[1]: 20  (~2,000 in R&D)[1]: 8  (2012)
Websiteallergan.com
Allergan headquarters in Irvine

Allergan, Inc., is a global specialty pharmaceutical company, focused on five areas: ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics.[2]

Profile

The company's most notable neurologic product is Botox, used around the world to treat a variety of debilitating disorders associated with muscle overactivity and also well-known—under the trade names Botox Cosmetic and Vistabel—for the treatment of facial lines.

Its most important manufacturing plants are in Waco, Texas; Westport, Ireland; and San Jose, Costa Rica. In 2012, the company opened a new clinical development facility in Bridgewater, New Jersey.[2]

On April 23, 2001, Allergan Inc. participated in annual meeting of the European Bank for Reconstruction and Development (London to Tues).[3]

Allergan is also a member of the American Legislative Exchange Council (ALEC).[4] They are the state corporate co-chair of Tennessee, a "Chairman" level sponsor of 2011 ALEC Annual Conference, and member of Louisiana Host Committee.[5]

Corporate Affairs

Acquisition

In March 1st, 2013, the company entirely acquired MAP Pharmaceuticals Inc., which is a development-stage company mainly researches on treatment of migraine and other oral drugs in Neurology. The pricipal products of this sub-company are under review with the US Food and Drug Administration (FDA). [6]

Safety reports

In 2011, FDA reported issues in the investigation of safety of Silicone Gel-Filled Breast Implants. However, Allergan announced later the reassurance to patients of the safety and exclusion of its drugs from the investigated breast implant devices, stating that all of its products are above safety standards around the world.[7]

Products

  • NATRELLE: Breast Implants (Silicone and Saline)
  • LAP-BAND: An adjustable gastric band, inserted laparoscopically (in most circumstances); a restrictive device implanted via bariatric surgery and designed for obese patients with a body mass index (BMI) of 40 or greater.
  • ORBERA SYSTEM: An intragastric balloon, inserted endoscopically; designed to assist weight loss by partially filling the stomach and inducing satiety for overweight patients with a body mass index (BMI) of 27 or greater.
  • LUMIGAN: anti-glaucoma medication containing the active ingredient bimatoprost.
  • Alphagan P: anti-(glaucoma) medication containing the active ingredient (brimonidine)
  • ACULAR
  • ACULAR LS
  • ACZONE: for Acne control
  • Acuvail
  • Pred Forte: 1% prednisolone acetate suspension for reducing swelling, redness, itching, and allergic reactions affecting the eye
  • ZYMAR .3%
  • Zymaxid .5%
  • F M L (fluorometholone)
  • Combigan: anti-(glaucoma) medication containing a combination of active ingredients (brimonidine) and (timolol)
  • BOTOX: anti-spasm medication containing the active ingredient botulinum toxin.
    • BOTOX COSMETIC: anti-wrinkle cosmetic drug derived from botox
    • VISTABEL: anti-wrinkle cosmetic drug derived from botox
  • REFRESH: artificial tears containing carboxymethylcellulose
    • CELLUVISC
    • DRY EYE THERAPY
      • Sensitive
    • LACRI-LUBE
    • LASTACAFT® (alcaftadine ophthalmic solution) 0.25%
    • LIQUIGEL
    • PLUS
    • P.M.
    • REDNESS RELIEF
    • TEARS
    • OPTIVE: most advanced retail dry-eye treatment
  • RESTASIS: dry eye treatment containing cyclosporine.
    • JUVEDERM: used cosmetically for wrinkles and fine lines
    • TAZORAC: for severe acne and psoriasis
    • LATISSE: used to lengthen and thicken eyelashes (attenuated version of Lumigan)
    • OZURDEX: for BRVO and CRVO
    • VIVITE: Complete Facial Line
    • SKINMEDICA: Complete Facial Line

Notes

  1. ^ a b c d e f g "Annual Report". Form 10-K. Allergan. 2012. Retrieved January 5, 2014.
  2. ^ a b Bhutta, Sunya (December 2013). "Biopharma Blossoming in the Garden State" (paper). Gen. Eng. Biotechnol. News. Vol. 33, no. 21. p. 15. Open access icon
  3. ^ "This Week".(registration required)
  4. ^ "ALEC Corporations". SourceWatch. September 2013. Archived from the original on January 5, 2014. Retrieved January 5, 2014. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  5. ^ "ALEC State Chairmen". SourceWatch. December 2, 2013. Tennessee. Archived from the original on January 5, 2014. Retrieved January 5, 2014. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  6. ^ https://www.google.com/finance?cid=630
  7. ^ http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=635213
Retrieved from "https://en.wikipedia.org/w/index.php?title=Allergan,_Inc.&oldid=594792046"